Found: 10
Select item for more details and to access through your institution.
Why is p53-inducible gene 3 rarely affected in cancer?
- Published in:
- 2010
- By:
- Publication type:
- Letter
Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study.
- Published in:
- Oncogene, 2008, v. 27, n. 23, p. 3256, doi. 10.1038/sj.onc.1210989
- By:
- Publication type:
- Article
p53 gene alterations in special types of breast carcinoma: A molecular and immunohistochemical study in archival material.
- Published in:
- Journal of Pathology, 1995, v. 176, n. 4, p. 361, doi. 10.1002/path.1711760407
- By:
- Publication type:
- Article
Stillbirth due to SARS-CoV-2 placentitis without evidence of intrauterine transmission to fetus: association with maternal risk factors.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy.
- Published in:
- Cell Death & Differentiation, 2015, v. 22, n. 11, p. 1764, doi. 10.1038/cdd.2015.21
- By:
- Publication type:
- Article
Oncogene-induced reactive oxygen species fuel hyperproliferation and DNA damage response activation.
- Published in:
- Cell Death & Differentiation, 2014, v. 21, n. 6, p. 998, doi. 10.1038/cdd.2014.16
- By:
- Publication type:
- Article
Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Imatinib for the treatment of refractory, diffuse systemic sclerosis.
- Published in:
- Rheumatology, 2008, v. 47, n. 5, p. 735, doi. 10.1093/rheumatology/ken104
- By:
- Publication type:
- Article
Absence of p53 gene mutations in skin fibroblasts derived from patients with systemic sclerosis.
- Published in:
- European Journal of Clinical Investigation, 2002, v. 32, n. 2, p. 139, doi. 10.1046/j.1365-2362.2002.00943.x
- By:
- Publication type:
- Article
c-mos immunoreactivity is an indicator of good prognosis in lung cancer.
- Published in:
- Histopathology, 2000, v. 37, n. 1, p. 45, doi. 10.1046/j.1365-2559.2000.00898.x
- By:
- Publication type:
- Article